Breakthrough in Cancer Treatment: Macrophage Membrane-Encapsulated Nanotherapeutics Show Promise

Strategic Insights -

Researchers from Tongji University have made a significant discovery in the fight against cancer, publishing a paper in the journal Theranostics detailing the use of macrophage membrane-encapsulated nanotherapeutics for targeted cancer therapy. According to the study, these nanotherapeutics display distinct characteristics such as avoiding premature leakage, tumor targeting ability, immune evasion, immune system activation, tumor-infiltrating ability, improved cell endocytosis, and release of payload in the tumor-microenvironment. The researchers believe that this review may be beneficial for improving the deep research of macrophage membrane-encapsulated nanotherapeutics for targeted cancer therapy.

Key Takeaways:

  • Macrophage membrane-encapsulated nanotherapeutics are a promising approach for targeted cancer therapy, with characteristics such as tumor targeting ability, immune evasion, and improved cell endocytosis.
  • The nanotherapeutics display specificity and avoid premature leakage, allowing them to effectively target cancer cells.
  • Macrophage membrane modification and immunization are key steps in developing effective nanotherapeutics for cancer therapy.
  • The researchers propose a future perspective to highlight the limitations of macrophage membrane-encapsulated nanotherapeutics and possible resolutions toward clinical transformation.
  • Tongji University researchers, including Maoquan Chu, Mubassir Khan, Razi Ullah, and Guixue Wang, are leaders in this area of research.
  • Funders for this research include the National Natural Science Foundation of China (NSFC), Natural Science Foundation of Shanghai, and Fundamental Research Funds for the Central Universities.

Statistics:

  • The study was published in the journal Theranostics in 2025, volume 15, issue 10, pages 4823-4847.
  • The research was conducted by researchers from Tongji University, Shanghai.
  • The nanotherapeutics were developed using macrophage membranes, with a focus on targeting cancer cells.
  • The study reports that the nanotherapeutics display improved cell endocytosis and release of payload in the tumor-microenvironment.
  • The research was funded by a total of 3 organizations, including the NSFC, Natural Science Foundation of Shanghai, and Fundamental Research Funds for the Central Universities.

Sources:

  • Macrophage Membrane-functionalized Nanotherapeutics for Tumor Targeted Therapy. Theranostics, 2025;15(10):4823-4847.
  • NewsRx. Reports from Tongji University Advance Knowledge in Cancer (Macrophage Membrane-functionalized Nanotherapeutics for Tumor Targeted Therapy). Vaccine Weekly. May 21, 2025; p 80.